Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma

Esophageal squamous carcinoma (ESCC) has a high morbidity and mortality rate. Identifying risk metabolites associated with its progression is essential for the early prevention and treatment of ESCC. A total of 373 ESCC, 40 esophageal squamous dysplasia (ESD), and 218 healthy controls (HC) subjects...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Mengjie, Wen, Wei, Yi, Xin, Zhu, Wei, Aa, Jiye, Wang, Guangji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859148/
https://www.ncbi.nlm.nih.gov/pubmed/35198450
http://dx.doi.org/10.3389/fonc.2022.829350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859148/
https://www.ncbi.nlm.nih.gov/pubmed/35198450
http://dx.doi.org/10.3389/fonc.2022.829350

Ejemplares similares